MAXIPHARMA
ActiveSummary
MAXIPHARMA has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €227,467 and a net result of €89,731. Equity is shrinking by about 7% per year across the filed financial years. Its solvency ranks better than 91% of 21,983 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Directors
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.